Plasma Fractionation Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Plasma Fractionation Market Research and
Forecast Report 2023-2028

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Plasma Fractionation Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2023-2028," the global plasma
  fractionation market size reached US 23.8
  Billion in 2022.
• Plasma fractionation is a sophisticated
  biomedical process for producing various
  therapeutic products derived from human blood
  plasma. The technique involves the separation of
  blood plasma into its constituent components,
  such as proteins, clotting factors, and
  immunoglobulins, through a series of
  fractionation steps. This intricate process
  transforms plasma into valuable medical products,
  including albumin, immunoglobulins, clotting
  factors, and other specialized proteins.
• These plasma-derived therapies are pivotal in
  treating various medical conditions, ranging from
  immune deficiencies and hemophilia to
  neurological disorders. The therapeutic
  significance of plasma fractionation lies in
  harnessing the potency of specific proteins
  within plasma to develop life-saving medications.
  Despite its complexity, technological
  advancements in plasma fractionation have
  improved efficiency, yield, and safety, producing
  high-quality, purified products. Plasma
  fractionation also plays a crucial role in
  addressing global health challenges by providing
  therapies for rare diseases and contributing to
  emergency preparedness, particularly during
  health crises.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/plasma-fractionation-ma
  rket/requestsample

4
Report Description

• Global Plasma Fractionation Market Trends
• The global market is majorly driven by the
  growing prevalence of diseases such as immune
  deficiencies, hemophilia, and autoimmune
  disorders. In line with this, the increasing
  demand for plasma-derived therapies is
  significantly contributing to the market growth.
  Furthermore, the rising global geriatric
  population, prone to age-related conditions,
  contributes significantly to the expanding demand
  for these therapies. Moreover, technological
  advancements in plasma fractionation processes
  enhance production efficiency, ensuring a
  reliable and high-quality supply of
  plasma-derived products. Besides, the growing
  awareness about the importance of plasma
  donation, coupled with improved screening
  processes, is increasing the availability of
  source material for fractionation.
• The expanding applications of plasma-derived
  products, extending beyond traditional uses to
  include treatments for neurological disorders and
  certain cancers, further stimulate market growth.
  Additionally, the COVID-19 pandemic has
  accentuated the importance of plasma-derived
  therapies, such as convalescent plasma, in
  addressing emerging health challenges. The
  strategic role of plasma fractionation in
  emergency preparedness and its contribution to
  healthcare solutions for rare diseases also
  contribute to the market's sustained expansion.
• Looking forward, the market value is projected to
  reach US 33.7 Billion by 2028, expanding at a
  CAGR of 5.8 during 2023-2028.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/plasma-fractionation-ma
  rket

5
Report Segmentation

• Breakup by Product
• Immunoglobulins
• Albumin
• Coagulation factor VIII
• Coagulation factor IX
• Breakup by Sector
• Private Sector
• Public Sector
• Breakup by Application
• Neurology
• Immunology
• Hematology

6
Report Segmentation

• Other Applications
• Breakup by End User
• Hospitals and Clinics
• Clinical Research Laboratories
• Academic Institutes
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• ADMA Biologics
• Bio Products Laboratory Ltd.
• Boccard
• Grifols, S.A.
• Hemarus Therapeutics Limited
• Intas Pharmaceuticals Limited
• LFB S.A.
• Merck Group
• Octapharma AG
• PlasmaGen BioSciences Pvt. Ltd.
• SK Plasma Co. Ltd.
• Virchow Biotech Private Limited.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Plasma Fractionation
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product    6.1  
   Immunoglobulins        6.1.1 Market Trends   
      6.1.2 Market Forecast    6.2    Albumin   
      6.2.1 Market Trends        6.2.2 Market
  Forecast    6.3    Coagulation factor VIII     
    6.3.1 Market Trends        6.3.2 Market
  Forecast       

11
Table of Contents

•     6.4    Coagulation factor IX        6.4.1
  Market Trends        6.4.2 Market Forecast7  
  Market Breakup by Sector    7.1    Private
  Sector        7.1.1 Market Trends        7.1.2
  Market Forecast    7.2    Public Sector       
  7.2.1 Market Trends        7.2.2 Market
  Forecast8   Market Breakup by Application   
  8.1    Neurology        8.1.1 Market Trends   
      8.1.2 Market Forecast    8.2    Immunology 
        8.2.1 Market Trends        8.2.2 Market
  Forecast    8.3    Hematology        8.3.1
  Market Trends        8.3.2 Market Forecast   
  8.4    Other Applications        8.4.1 Market
  Trends        8.4.2 Market Forecast9   Market
  Breakup by End User    9.1    Hospitals and
  Clinics        9.1.1 Market Trends        9.1.2
  Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/plasma-fractionation-market/toc

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com